Clinical Trial Update: Phase 3b Study to Evaluate Advagraf in Combination With Mycophenolate Mofetil and Basiliximab in Liver Transplantation [Phase 3]

View source ↗

Summary

Phase 3b trial evaluating Advagraf in combination with mycophenolate mofetil and basiliximab in liver transplantation has completed; no efficacy results are des…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• Advagraf (tacrolimus)
• Basiliximab (basiliximab)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Liver Transplantation | Phase 3 | Status: COMPLETED